Literature DB >> 2064962

Expression of coagulation factor V gene by normal adult human hepatocytes in primary culture.

M Mazzorana1, G Baffet, B Kneip, B Launois, C Guguen-Guillouzo.   

Abstract

Normal human adult hepatocytes were examined for their ability to synthesize and secrete factor V using primary culture. The culture medium contained both factor V and factor Va as determined by bioassay and activation experiments. Immunoprecipitation of newly synthesized labelled factor V showed the presence of both native factor V (m.w. 330,000) and two fragments of respective molecular weight 300,000 and 265,000. Northern blot analysis revealed the presence of a single 7 kb factor V mRNA in cultured human hepatocytes as in liver biopsies, together with fibrinogen beta and albumin transcripts. Relative levels of factor V, fibrinogen beta and albumin mRNAs differed when the cells cultured, suggesting that expression of the three corresponding genes might in part be independently regulated. Furthermore, addition of glucocorticoids enhanced factor V and fibrinogen beta mRNA levels 1.6- and 5-fold respectively, but did not significantly increase that of albumin. These results provide evidence that human hepatocytes actively participate in the synthesis of plasma factor V and constitute a valuable model to study the common and specific regulations involved in the control of the expression of this gene in human liver.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2064962     DOI: 10.1111/j.1365-2141.1991.tb04421.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  2 in total

1.  Identifying and enriching platelet-producing human stem cell-derived megakaryocytes using factor V uptake.

Authors:  Xiuli Sim; Danuta Jarocha; Vincent Hayes; Hayley A Hanby; Michael S Marks; Rodney M Camire; Deborah L French; Mortimer Poncz; Paul Gadue
Journal:  Blood       Date:  2017-04-28       Impact factor: 22.113

2.  Clinical Phenotype and Genetic Analysis of Twins With Congenital Coagulation Factor V Deficiency.

Authors:  Yanhui Wei; Yuzhuo He; Xuejun Guo
Journal:  J Pediatr Hematol Oncol       Date:  2022-03-01       Impact factor: 1.170

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.